
CARsgen Therapeutics Holdings Ltd
HKEX:2171

Intrinsic Value
The intrinsic value of one
CARsgen Therapeutics Holdings Ltd
stock under the Base Case scenario is
0.5
HKD.
Compared to the current market price of 10.76 HKD,
CARsgen Therapeutics Holdings Ltd
is
Overvalued by 95%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CARsgen Therapeutics Holdings Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
CARsgen Therapeutics Holdings Ltd
Balance Sheet Decomposition
CARsgen Therapeutics Holdings Ltd
Current Assets | 1.5B |
Cash & Short-Term Investments | 1.5B |
Receivables | 28.1m |
Other Current Assets | 23.1m |
Non-Current Assets | 142.8m |
PP&E | 123.9m |
Intangibles | 2.9m |
Other Non-Current Assets | 15.9m |
Free Cash Flow Analysis
CARsgen Therapeutics Holdings Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
CARsgen Therapeutics Holdings Ltd
Revenue
|
39.4m
CNY
|
Cost of Revenue
|
-24.7m
CNY
|
Gross Profit
|
14.7m
CNY
|
Operating Expenses
|
-822.9m
CNY
|
Operating Income
|
-808.2m
CNY
|
Other Expenses
|
10.1m
CNY
|
Net Income
|
-798.1m
CNY
|
Profitability Score
Profitability Due Diligence
CARsgen Therapeutics Holdings Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Score
CARsgen Therapeutics Holdings Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
CARsgen Therapeutics Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Score
CARsgen Therapeutics Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
CARsgen Therapeutics Holdings Ltd
According to Wall Street analysts, the average 1-year price target for
CARsgen Therapeutics Holdings Ltd
is 10.49 HKD
with a low forecast of 9.15 HKD and a high forecast of 12.08 HKD.
Dividends
Current shareholder yield for CARsgen Therapeutics Holdings Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CARsgen Therapeutics Holdings Ltd
stock under the Base Case scenario is
0.5
HKD.
Compared to the current market price of 10.76 HKD,
CARsgen Therapeutics Holdings Ltd
is
Overvalued by 95%.